(Q54568296)

1 June 2018

title

Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. (English)

1 reference

1 June 2018

0 references

0 references

1 reference

4

1 reference

1 June 2018

Toshifumi Hibi

14

object named as

Toshifumi Hibi

1 reference

1 June 2018

author name string

Katsuyoshi Matsuoka

1

1 reference

1 June 2018

Yasushi Iwao

2

1 reference

1 June 2018

Takeshi Mori

3

1 reference

1 June 2018

Tomoharu Yajima

5

1 reference

1 June 2018

Tadakazu Hisamatsu

6

1 reference

1 June 2018

Susumu Okamoto

7

1 reference

1 June 2018

Yuichi Morohoshi

8

1 reference

1 June 2018

Motoko Izumiya

9

1 reference

1 June 2018

Hitoshi Ichikawa

10

1 reference

1 June 2018

Toshiro Sato

11

1 reference

1 June 2018

Nagamu Inoue

12

1 reference

1 June 2018

Haruhiko Ogata

13

1 reference

1 June 2018

language of work or name

English

0 references

publication date

11 December 2006

1 reference

1 June 2018

The American Journal of Gastroenterology

published in

1 reference

1 June 2018

volume

102

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

page(s)

331-337

1 reference

1 June 2018

Gastrointestinal cytomegalovirus disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Outcome of cytomegalovirus infections in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

A prospective assessment of cytomegalovirus infection in active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Combined-modality therapy in locally advanced primary rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Quantitative pp65 antigenemia in the diagnosis of cytomegalovirus disease: prospective assessment in a cohort of solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00989.X

10.1111/J.1572-0241.2006.00989.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018